Cargando…
Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
SIMPLE SUMMARY: Immunotherapy has played a pivotal role in the management of relapsed DLBCL. Stem cell transplant and CAR T-cell therapy are curative treatment modalities for relapsed disease. Despite this, a subset of patients continues to progress, and their outcomes remain dismal. Newer therapeut...
Autores principales: | Modi, Dipenkumar, Potugari, Bindu, Uberti, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616088/ https://www.ncbi.nlm.nih.gov/pubmed/34830980 http://dx.doi.org/10.3390/cancers13225827 |
Ejemplares similares
-
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022) -
Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Zhang, Jun, et al.
Publicado: (2018) -
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021) -
Current landscape and future directions of bispecific antibodies in cancer immunotherapy
por: Wei, Jing, et al.
Publicado: (2022) -
Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
por: Ames, Ashley, et al.
Publicado: (2022)